PE-Backed Biotech Co. Egalet Prepares $69M IPO
Egalet is developing an abuse-resistant method to deliver pain-relieving drugs such as morphine orally. The company has completed multiple rounds of venture financing and counts Atlas Venture, Switzerland's Index Ventures and Norway's Sunstone Capital among its backers.
"Prescription medications, particularly opioids, are prone to...
To view the full article, register now.